Newsroom


Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance

DURHAM, NC – August 10, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…

Read More

Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix

The Combination Further Differentiates Bioventus’ Product Portfolio and Accelerates Its Revenue Growth Significantly Expands TAM and Adds…

Read More

Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance

DURHAM, NC – July 29, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…

Read More

Bioventus Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference

DURHAM, NC – July 27, 2021 – Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…

Read More

Bioventus Appoints Mary Kay Ladone to Board of Directors

DURHAM, NC – July 14, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide

DURHAM, NC – July 13, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, is…

Read More

Bioventus Invests in Vaporox

Ultrasonic Technology to Heal Diabetic Foot Ulcers DURHAM, NC – June 24, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global…

Read More

Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021

DURHAM, NC – June 16, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…

Read More

Bioventus Study Shows Novel Placental Tissue Biologic Candidate Inhibited Inflammatory and Catabolic Responses In Vitro

Demonstrated Significant Reduction of Pain and Cartilage Degeneration in Rat Osteoarthritis Model DURHAM, NC – May 25, 2021 – Bioventus Inc. (Nasdaq:…

Read More

Bioventus Senior Management to Present at Upcoming Investor Conferences

DURHAM, NC – May 17, 2021 – Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…

Read More

Search News


Media Inquiries


Jamica Whitaker
Communications Manager
919.666.5770
[email protected]

Download Library


Corporate and Brand Logos
Download Now

Product Images
Download Now